Inflammation Tissue Articles & Analysis
19 news found
Each tissue microarray is constructed from paraffin-embedded (FFPE) tissue blocks from a specific number of donor cases. ...
Creative Enzymes is a leading biotechnology company supporting the development of diagnostic enzymes for kidney and pancreatic diseases. Pancreatitis is inflammation of the pancreatic tissue, which can be either acute or chronic. Pancreatic enzymes, including amylase, lipase, and trypsin, can be used to monitor the relative health of the pancreas. Damage to the ...
We believe MINIject®’s distinctive tissue-integrating capabilities unlock a safer, and more effective option for patients. ...
We believe MINIject®’s distinctive tissue-integrating capabilities unlock a safer, and more effective option for patients. ...
We believe MINIject®’s distinctive tissue-integrating capabilities unlock a safer, and more effective option for patients. ...
The phenomenon that rheumatoid inflammation disappears when a patient with rheumatoid arthritis suffers from jaundice was discovered by Philip Hench, a professor at the Mayo Clinic in the United States, who was awarded the Nobel Prize in Physiology or Medicine. ...
Use of microMend produces less inflammation and tissue damage, which cause scarring. It also eliminates wound gaps and reduces skin irritation. ...
Vold, from Vold Vision in Fayetteville, AR (USA), a long-standing contributor to ophthalmic device development and STAR-V trial investigator commented: “There is significant untapped potential in targeting the supraciliary space when leveraging MIGS to treat glaucoma, and MINIject enables this to be captured. iSTAR Medical’s approach uses its unique silicone micropore ...
Aldosterone-mediated activation of mineralocorticoid receptors (MR) in the kidney drive the downward spiral by promoting tissue inflammation and injury. Finerenone is an investigational, non-steroidal, selective MR antagonist that in preclinical studies has been shown to block harmful effects of MR overactivation, which is thought to contribute to CKD progression ...
ByBayer AG
SLE is a chronic and relapsing autoimmune disease characterized by a break-down of self-tolerance that leads to tissue inflammation and multiorgan damage. SLE is extremely heterogeneous in nature, with the signs and symptoms varying from person to person, which can often lead to delays in diagnosis. ...
A burst of hydrogen peroxide causes neutrophils, the immune system’s first responders, to rush to the wound to fight microorganisms, remove damaged tissue and then start the inflammation process. University of Wisconsin-Madison researchers now have discovered the molecular sensor that detects wound-induced hydrogen peroxide and orchestrates the marshalling ...
Professor Ann Logan, from the University of Warwick, leader of the research team and senior author of the publication, said, “Inflammation plays a vital role in healing, but when it becomes uncontrolled the immune system starts damaging healthy cells, tissues, and organs causing scarring that compromises function. ...
NNI states that while there have been significant advances in developing implantable sensors for monitoring and responding to tissue growth, infection, and inflammation surrounding implants, as well as communicating such responses to hand held devices for real-time responses, obstacles include the use of non-toxic sensor chemistries, information storage, ...
The phenomenon in which rheumatoid arthritis patients get jaundice causes rheumatoid inflammation to disappear when Nobel laureate in Physiology or Medicine Philip Hench, a professor at the Mayo Clinic in the U.S., discovered the phenomenon. ...
“DDD is a complex medical condition characterized by inflammation and breakdown of intervertebral disc tissue, making it a highly complicated environment to heal,” said Domagoj Coric, M.D. of Carolina Neurosurgery and Spine Associates and Spine Division Chief of Atrium’s Musculoskeletal Institute as well as the study’s principal ...
About tiakis Elafin clinical development program tiakis biopharmaceutical drug candidate Elafin promises an excellent therapeutic benefit risk profile for the use as an anti-inflammatory and tissue protective drug. Elafin is identical to the human protein elafin with high specificity for tissue destroying and inflammation promoting proteases. ...
About tiakis Elafin clinical development program tiakis biopharmaceutical drug candidate Elafin promises an excellent therapeutic benefit risk profile for the use as an anti-inflammatory and tissue protective drug. Elafin is identical to the human protein elafin with high specificity for tissue destroying and inflammation promoting proteases. ...
Up until now, local inflammation and scar tissue from the so-called “foreign body response” has prevented the development of in-body sensors capable of continuous, long-term monitoring of body chemistry. ...
The team was interested in how oxidation, cell and tissue damage resulting from exposure to molecules known as free radicals, contributes to inflammation and artery disease. ...